Julian Gray is a physician working in medicines development for 30 years internationally.
Dr Gray studied medicine in the UK , obtaining a BA with first class honours from Oxford University in 1978 and MBBS from the University of London in 1981. He subsequently undertook training in internal medicine, clinical pharmacology and neurology obtaining the Membership of the Royal College of Physicians (UK) in 1984 and a D.Phil (PhD) in neuropharmacology from Oxford University in 1988.He has an MBA from Oxford Brookes University and holds the title of Specialist in Pharmaceutical Medicine in Switzerland.
In 1988 he took up a position of medical expert at Sandoz in Basel, developing drugs in the neurology area including the early clinical studies of Exelon in Alzheimer's disease. In 1992 he took up the position of International Clinical Leader at Hoffmann La Roche in Basel, leading the development of clinical projects globally. He gained experience also in business aspects during this time through an attachment in the strategic marketing and business development department, completing a thesis on financial and strategic aspects of codevelopment and obtaining an MBA with distinction from Oxford Brookes University. He subsequent left to become Vice President of Clinical R&D at Praecis Pharmaceuticals in Cambridge Massachusetts to work on an early stage project in Alzheimer's disease. In 2000 he took up the role of head of CNS clinical area at Eisai, based in London, leading early and late stage clinical projects globally. Since 2004 he has worked as a consultant to the industry on medicines development, taking a leading role in CNS projects on a day to day basis on behalf of companies internationally.
He previously established a successful course for the MRCP examination, which ran for 10 years in Guildford UK and been a longstanding member of the teaching faculty of the European Course in Pharmaceutical Medicine at the University of Basel He has participated in its sister courses, ACDRS in the US and CCDRS at the Peking University Medical School in China. He is the principal teacher of the Drug Development module of the Clinical Trial Professional Course at the University Hospital of Basel. The work to produce Gray's Medicines Development, commenced in 2006 and the text has been continually updated since then.